Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02790463 · ClinicalTrials.gov registry record · NA
Virtual Gout Clinic
A NA study of Gout, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 1,463
- Enrollment target
- 2
- Study locations
NCT02790463: Completed NA study of Gout, sponsored by University of Alabama at Birmingham.
NCT02790463 is a NA study of Gout that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,463 participants, below the 8,845-participant average among 34 other Gout trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02790463, a NA study of Gout, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,463 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overarching goal of the investigators project is to identify best practices in gout and hyperuricemia management, translate these evidence-based practices into a highly generalizable strategy for optimal delivery of gout care, and implement and evaluate such a strategy in a large, population-based healthcare setting. With the use of novel but readily-accessible technology, the investigators will examine the use of a novel, large-scale, and relatively low-cost pharmacy-based intervention, with the goal of optimizing urate lower therapy (ULT) in chronic gout treatment.
Primary Outcome
Achievement of serum uric acid (sUA) \< 6.0 mg/dl at 1 year
Conditions Studied
Interventions
- BEHAVIORAL Pharmacist-Led Intervention
Study Locations (2)
Alabama
- University of Alabama at Birmingham - Birmingham
California
- Kaiser Permanente - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,463 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02790463 record still lists
NCT02790463 is an interventional study that assigns participants to a tested intervention. Its 1,463 participants enrollment target places it among the larger protocols in the corpus, below the 8,845-participant average among 34 other Gout trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Gout appearing as the primary indexed condition, and to 1 intervention - of which Pharmacist-Led Intervention is the first listed.
NCT02790463 reports a single indexed study location in Alabama, California.
Frequently Asked Questions
What is clinical trial NCT02790463 about?
NCT02790463 is a clinical study titled "Virtual Gout Clinic". The overarching goal of the investigators project is to identify best practices in gout and hyperuricemia management, translate these evidence-based practices into a highly generalizable strategy for optimal delivery of gout care, and implement and evaluate such a strategy in a large, population-bas...
What is the current status of trial NCT02790463?
This trial is currently completed. It is a NA study. The enrollment target is 1,463 participants. The study started on 2013-01. Estimated completion is 2018-10.
What conditions does trial NCT02790463 study?
This clinical trial studies the following conditions: Gout.
What interventions are being tested in trial NCT02790463?
The interventions under investigation include: Pharmacist-Led Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02790463?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02790463 being conducted?
This trial has 2 study locations across Alabama, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gout
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02790463's enrollment target sits among peer trials
1,463 2nd of 34 the highest of 34 other Gout trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gout trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Improving Gout Care After an ED Visit
RECRUITING · NA
-
Gout in the ED and Improving Research Participation
ACTIVE NOT RECRUITING · NA
-
Novel Methods for Ascertainment of Gout Flares -A Pilot Study
COMPLETED · NA
-
The Diet Gout Trial
COMPLETED · NA
-
Pharmacokinetics and Pharmacodynamics of Anthocyanins
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia